DNA X, Inc.
SONM
$4.75
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 7.94% | -2.83% | -0.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 7.94% | -2.83% | -0.33% |
| Cost of Revenue | -- | -- | 33.44% | -12.06% | -- |
| Gross Profit | -- | -- | -57.09% | 440.73% | -- |
| SG&A Expenses | 315.86% | 43.01% | -4.72% | 17.71% | -83.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 315.86% | 35.11% | 16.07% | -0.36% | -95.53% |
| Operating Income | -315.86% | -26.78% | -67.51% | -4.05% | 67.65% |
| Income Before Tax | -308.74% | -43.59% | -94.70% | -11.51% | 65.44% |
| Income Tax Expenses | -- | -- | -23.08% | 275.68% | -- |
| Earnings from Continuing Operations | -308.74% | -42.80% | -89.21% | -12.98% | 66.93% |
| Earnings from Discontinued Operations | 623.61% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,284.28% | 58.88% | -89.21% | -12.98% | 115.76% |
| EBIT | -315.86% | -26.78% | -67.51% | -4.05% | 67.65% |
| EBITDA | -1,474.59% | -17.94% | -107.68% | -5.51% | 110.23% |
| EPS Basic | 255.00% | 88.56% | 48.25% | 44.34% | 111.98% |
| Normalized Basic EPS | -4.82% | -70.30% | 46.75% | 49.52% | 73.74% |
| EPS Diluted | 255.00% | 88.64% | 48.20% | 44.05% | 111.98% |
| Normalized Diluted EPS | -4.82% | -70.30% | 46.75% | 49.52% | 73.74% |
| Average Basic Shares Outstanding | 289.98% | 175.73% | 265.59% | 103.00% | 31.55% |
| Average Diluted Shares Outstanding | 289.98% | 175.73% | 265.59% | 103.00% | 31.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |